Prompt Antiviral Treatment Cuts Pediatric Flu Hospitalization Risk in Study
A retrospective case-control study from Taiwan found that children with influenza who received antiviral therapy within 48 hours of symptom onset had an 81% lower risk of hospitalization. The protective effect was similar across age groups and for both oseltamivir and zanamivir. Researchers emphasized that early antivirals should supplement, not replace, vaccination.
The Taiwanese investigation drew from a hospital network serving as a primary pediatric care hub in northern Taiwan, comparing 354 hospitalized children against 1,138 non-hospitalized peers. The protective benefit held steady across age brackets, including children five and under, and applied equally to both oseltamivir and zanamivir.
Despite global guidelines endorsing early treatment, a recent U.S. survey of clinicians revealed that a minority would prescribe oseltamivir to outpatient children. Accompanying commentary stresses that antivirals should complement vaccination, particularly for infants under six months who cannot yet receive a flu shot, and may also curb household spread and speed up recovery.
This evidence could prompt more pediatricians to prescribe antivirals early, potentially easing hospital strain during severe flu seasons. Parents may feel more empowered to seek prompt medical care for sick children, knowing treatment reduces severe outcomes. However, it may also inadvertently lower vaccination uptake if caregivers view antivirals as a substitute, though experts explicitly caution against this. The findings could influence public health messaging to emphasize early treatment as a complementary safety net, especially for unvaccinated or ineligible infants.